You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Challenging Cases in Alzheimer’s Disease: Applying Strategies to Inform Timely and Accurate Diagnosis

  • Authors: Richard Isaacson, MD; Larry Culpepper, MD, MPH; Henrik Zetterberg, MD, PhD​
  • CME / ABIM MOC / CE Released: 2/24/2022
  • Valid for credit through: 2/24/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.75 ABIM MOC points

    Nurses - 0.75 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for primary care physicians, neurologists, nurses (including internal medicine, family practice, geriatric medicine), AD specialists, dementia specialists, neurologists, nurse practitioners, and physician assistants.

The goal of this activity is to increase ability of clinicians to identify and assess patients suspected of having mild cognitive impairment.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Tools for evaluating cognitive impairment in clinical practice
  • Have greater competence related to
    • Recognition of early signs and symptoms of mild cognitive impairment
  • Demonstrate greater confidence in their ability to
    • Perform an evaluation in patients suspected of having AD


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Faculty

  • Richard Isaacson, MD

    Director of the Alzheimer’s Prevention Clinic
    Florida Atlantic University Schmidt College of Medicine
    Boca Raton, Florida, United States​
    Adjunct Associate Professor of Neurology
    Weill Cornell Medicine
    New York, New York​, United States

    Disclosures

    Advisor or consultant for: Acadia; Avandia; Biogen; Genentech/Roche; Lilly; Novo Nordisk
    Speaker or member of speakers bureau:  Biogen

  • Larry Culpepper, MD, MPH

    Professor of Family Medicine
    Boston University School of Medicine
    Dept. of Family Medicine
    Boston, Massachusetts, United States

    Disclosures

    Advisor or consultant for: AbbVie Pharmaceuticals; Acadia Pharmaceuticals; Allergan Pharmaceuticals; Eisai Pharmaceuticals; Supernus Pharmaceuticals Inc.; Takeda Pharmaceuticals
    Owns stock:  M-3 Information, LLC.

  • Henrik Zetterberg, MD, PhD

    Professor of Neurochemistry​
    Chief Physician​
    Institute of Neuroscience and Physiology
    Sahlgrenska Academy
    University of Gothenburg
    Mölndal, Sweden​

    Disclosures

    Advisor or consultant for: Abbvie; Alector; Annexon; Artery Therapeutics; AZTherapies; CogRx; Denali; Eisai; Nervgen; Pinteon Therapeutics; Red Abbey Labs; Passage Bio; Roche; Samumed; Siemens Healthineers; Triplet Therapeutics; Wave
    Speaker or member of speakers bureau for: Alzecure; Biogen; Cellectricon; Fujirebio; Roche

Editor

  • Lisette Arnaud-Hevi, PhD

    Medical Education Director, Medscape, LLC 

    Disclosures

    Disclosure: Lisette Arnaud-Hevi, PhD, has no relevant financial relationships. 

Compliance Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC 

    Disclosures

    Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Challenging Cases in Alzheimer’s Disease: Applying Strategies to Inform Timely and Accurate Diagnosis

Authors: Richard Isaacson, MD; Larry Culpepper, MD, MPH; Henrik Zetterberg, MD, PhD​Faculty and Disclosures

CME / ABIM MOC / CE Released: 2/24/2022

Valid for credit through: 2/24/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

The journey along the pathophysiological–clinical AD continuum

Dr Isaacson provides a brief overview of the initial clinical symptoms and pathophysiological mechanisms of AD.
Richard Isaacson, MD

Signs, Symptoms, and Evaluation of MCI

Dr Culpepper presents some of the instruments PCPs can use to rapidly assess if a patient with cognitive decline goes beyond normal aging.
Larry Culpepper, MD, MPH

What Should Trigger Suspicion of MCI and How To Perform an Evaluation for AD

Dr Isaacson and Dr Zetterberg compare the steps and tools to achieve a differential diagnosis of MCI due to AD in the US and EU.
Richard Isaacson, MD, and Henrik Zetterberg, MD, PhD

Educational Impact Challenge

The goal of this activity is to increase ability of clinicians to identify and assess patients suspected of having mild cognitive impairment.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print